Cell Line Information:
Designations: WI-38
Depositors: L Hayflick
Growth Properties: adherent
Organism: Homo sapiens
Morphology: fibroblast
Source: Organ: lung
Disease: normal
Cell Type: fibroblast
Applications: Transfection host; viruscide testing
Cytogenetic Analysis:normal diploid
Isoenzymes: G6PD, B
Age: 3 months gestation fetus
Gender: female
Ethnicity: Caucasian
The WI-38 human diploid cell line was derived by Leonard Hayflick from normal embryonic (3 months gestation) lung tissue. WI-38 cells have a finite lifetime of 50 plus or minus 10 population doublings with a doubling time of 24 hours. This line was the first human diploid cell line to be used in human vaccine preparation.
The Transfection Reagent:
WI-38 Cell Avalanche™ Transfection Reagent is a new, proprietary solution specifically designed for transfection on WI-38 Cells. The proprietary formulation of lipids and polymers ensures the highest possible transfection efficiencies and viabilities for WI-38 Cells. No other transfection reagents can match the efficiency, convenience, and gentleness of WI-38 Cell Avalanche™ Transfection Reagent for transfection on WI-38 Cells. For details of the developing process of this reagent, please go to: How did EZ Biosystems develop Avalanche™ Cell type/cell line specific transfection reagent series?
Features:
Data: | ||||||
| ||||||
For Other Cells: | ||||||
WI-38 Cell Avalanche™ Transfection Reagent can also be used on the following cells with high transfection efficiencies. Caki-1 Cell |
If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200
Cambio成立于1985年,是一家私人控股的英国公司,在为大学、大型制药、生物技术、政府机构、农业组织和环境设施的科研实验室提供优质分子生物学试剂和耗材方面享有盛誉。
我们的产品来源于全球领先制造商网络,我们对我们长期的客户和供应商关系感到非常自豪,这促使Cambio致力于:
不断推出新产品
有竞争力的定价
无应力顺序排列
世界一流的技术支持
为了满足日益增长和多样化的市场需求,我们不断增加先进的分子生物学产品到我们广泛的产品组合中。我们目前的产品范围包括以下研究工具:
适体
农业食品诊断
细胞毒性和致突变性检测试剂盒
微阵列
寡合成
细胞培养污染控制
DNA和RNA测序
分子生物学用酶
染色体画
样品制备
分子克隆
转体
体外翻译
基因表达分析
塑料消耗品
无论您是在线购买、电话购买还是传真购买,客户满意都是我们的首要任务。如果你很难找到你要找的东西,请给我们打电话或发邮件。我们承诺快速反应和有竞争力的折扣批量购买。
Cambio已通过ISO9001:2008注册(查看证书)
有趣的事实:
1986年,我们的创始董事彼得·迪恩(Peter Dean)与马丁·埃文斯(Martin Evans,现为教授)合作,开发了第一台使用专利“智能加热块(IHB)”技术进行PCR反应的机器,用于实时温度控制